Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Compass Therapeutics (CMPX) Shares Issued: 2023-2025

  • Compass Therapeutics' Shares Issued was N/A to $138.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.3 million, marking a year-over-year change of. This contributed to the annual value of $18.1 million for FY2024, which is 479.43% up from last year.
  • Compass Therapeutics' Shares Issued amounted to $138.0 million in Q3 2025, which was up 661.88% from $18.1 million recorded in Q1 2024.
  • Over the past 5 years, Compass Therapeutics' Shares Issued peaked at $138.0 million during Q3 2025, and registered a low of $41,000 during Q1 2023.
  • Its 3-year average for Shares Issued is $39.8 million, with a median of $10.6 million in 2023.
  • Data for Compass Therapeutics' Shares Issued shows a peak YoY surged of 44,078.05% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Compass Therapeutics' Shares Issued stood at $3.1 million in 2023, then skyrocketed by 44,078.05% to $18.1 million in 2024, then reached $138.0 million in 2025.
  • Its Shares Issued was $138.0 million in Q3 2025, compared to $18.1 million in Q1 2024 and $3.1 million in Q2 2023.